Utah Med (UTMD): Rasio kapitalisasi pasar marang pendapatan

A conservative approach to quality control and personnel policy minimizes operational risks for Utah Medical Products (UTMD). The current price-to-sales ratio visualizes this stability, with 6.50 serving as the final level marker. Resilience is driven by high-margin niches in neonatology and gynecology. Long-term clinical dependence on the brand's consumables guarantees a steady cash flow, confirming the strength of the business model.
Rincian metrik lan analitis perusahaan Utah Medical (UTMD)

The P/S ratio determines the market value of a business relative to its actual sales volume, allowing for an assessment of the premium paid per unit of revenue. Analyzing the price-to-sales metric helps identify the fair value of Utah Medical Products (UTMD), where the high margins of specialized medical plastics and patent protection make the model scalable, ensuring operational efficiency with minimal production costs.